INFORMATIVE BIOMARKERS OF PORTAL HYPERTENSION

The present inventors provide non-invasive biomarkers (E-cadherin (ECAD) and/or SPINK1) for the diagnosis and prognosis of portal hypertension.Advantageously, the markers of the invention also allow to appropriately differentiate between the non-clinical and clinically significant portal hypertensio...

Full description

Saved in:
Bibliographic Details
Main Authors GRACIA SANCHO, Jordi, GARCIA PAGÁN, Joan Carles, ORTEGA RIBERA, Martí, GIBERT RAMOS, Albert, MAGAZ MARTÍNEZ, Marta
Format Patent
LanguageEnglish
French
German
Published 08.02.2023
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present inventors provide non-invasive biomarkers (E-cadherin (ECAD) and/or SPINK1) for the diagnosis and prognosis of portal hypertension.Advantageously, the markers of the invention also allow to appropriately differentiate between the non-clinical and clinically significant portal hypertension, thus being possible a more precise management of the therapeutic protocols.
Bibliography:Application Number: EP20210382731